Stock LA JOLLA PHARM
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. LA JOLLA PHARM Other OTC

Equities

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for LA JOLLA PHARM
2022 La Jolla Pharmaceutical Announces Management Changes CI
2022 La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from NASDAQ Composite Index CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
LA JOLLA PHARMACEUTICAL : Chardan Suspends Coverage on La Jolla Pharmaceutical at Buy Rating With $15 Price Target
MT
LA JOLLA PHARMACEUTICAL : Chardan Adjusts La Jolla Pharmaceutical's Price Target to $15 From $20, Keeps at Buy
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LJPC Stock
  4. Stock
  5. News LA JOLLA PHARM
  6. Analyst Reco.